Arkolith/Insider Trading/LXEO/Form 4/A

Townsend Richard Nolan

Chief Executive Officer, DirectorLexeo Therapeutics, Inc. (LXEO) · full profile →Form 4/A · filed Sep 10, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5K
Net Open-Market Flow
-$5K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 18, 2025Sell(S)1K$4.67$5K220K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001415889-25-024104) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML